(Q45155015)

10 December 2017

title

Short-term infusion of interleukin-6 does not induce insulin resistance in vivo or impair insulin signalling in rats (English)

1 reference

10 December 2017

1 reference

1 reference

4

A Holmäng

1 reference

10 December 2017

3

A Johansson

1 reference

10 December 2017

V Rotter Sopasakis

1

1 reference

10 December 2017

B-M Larsson

series ordinal

2

1 reference

10 December 2017

U Smith

series ordinal

5

1 reference

10 December 2017

publication date

17 November 2004

1 reference

10 December 2017

1 reference

10 December 2017

volume

47

1 reference

10 December 2017

issue

11

1 reference

10 December 2017

page(s)

1879-1887

1 reference

Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.

10 December 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-004-1544-Y

Muscle-derived interleukin-6: lipolytic, anti-inflammatory and immune regulatory effects

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-004-1544-Y

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-004-1544-Y

Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women.

21 January 2018

1 reference

12 December 2020

Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes

1 reference

12 December 2020

Adiponectin gene activation by thiazolidinediones requires PPAR gamma 2, but not C/EBP alpha-evidence for differential regulation of the aP2 and adiponectin genes

1 reference

12 December 2020

Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans

1 reference

12 December 2020

Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice

1 reference

12 December 2020

Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by beta-adrenergic activation and effects of IL-6 on adipocyte function

1 reference

12 December 2020

Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia

1 reference

12 December 2020

The differential effect of food intake and beta-adrenergic stimulation on adipose-derived hormones and cytokines in man.

1 reference

12 December 2020

Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors

1 reference

12 December 2020

SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice

1 reference

12 December 2020

Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulin-stimulated glucose transport

1 reference

12 December 2020

Insulin decreases human adiponectin plasma levels

1 reference

12 December 2020

Interleukin-6 induces cellular insulin resistance in hepatocytes

1 reference

12 December 2020

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway

1 reference

12 December 2020

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

1 reference

12 December 2020

Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.

1 reference

12 December 2020

Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity

1 reference

12 December 2020

Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys

1 reference

12 December 2020

Interleukin 6 and its receptor: ten years later

1 reference

12 December 2020

Expression of suppressors of cytokine signaling during liver regeneration

1 reference

12 December 2020

Parathyroid hormone induces hepatic production of bioactive interleukin-6 and its soluble receptor

1 reference

12 December 2020

Interleukin-6 stimulates hepatic triglyceride secretion in rats

1 reference

12 December 2020

Interleukin-6 production by contracting human skeletal muscle: autocrine regulation by IL-6

1 reference

12 December 2020

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

1 reference

12 December 2020

Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

1 reference

12 December 2020

Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM.

1 reference

12 December 2020

Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone.

1 reference

12 December 2020

Gene regulation by interleukin 6.

1 reference

12 December 2020

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

1 reference

12 December 2020

Gene expression of receptors for IL-6, LIF, and CNTF in regenerating skeletal muscles

1 reference

12 December 2020

Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid

1 reference

12 December 2020

Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Endocrinologic and metabolic effects of interleukin-6 in humans

1 reference

12 December 2020

SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2

1 reference

12 December 2020

Growth impairment in IL-6-overexpressing transgenic mice is associated with induction of SOCS3 mRNA.

1 reference

12 December 2020

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

1 reference

12 December 2020

Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis

1 reference

12 December 2020

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

12 December 2020

Interleukin-6 stimulates lipolysis and fat oxidation in humans

1 reference

12 December 2020

Adiponectin expression in adipose tissue is reduced in first-degree relatives of type 2 diabetic patients

1 reference

12 December 2020

Interleukin-6-deficient mice develop mature-onset obesity

1 reference

12 December 2020

Effects of testosterone on muscle insulin sensitivity and morphology in female rats.

1 reference

12 December 2020

Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes

1 reference

12 December 2020

Dose-dependent effects of recombinant human interleukin-6 on glucose regulation.

1 reference

12 December 2020

High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator

1 reference

12 December 2020

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

1 reference

12 December 2020

10.1007/S00125-004-1544-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

10 December 2017

1002371358

0 references

1 reference